Schroder Investment Management Group lifted its holdings in shares of Exelon Co. (NASDAQ:EXC - Free Report) by 86.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,576,632 shares of the company's stock after acquiring an additional 732,355 shares during the quarter. Schroder Investment Management Group owned 0.16% of Exelon worth $59,329,000 at the end of the most recent quarter.
A number of other hedge funds also recently made changes to their positions in the business. Vanguard Group Inc. lifted its stake in Exelon by 2.5% in the 4th quarter. Vanguard Group Inc. now owns 127,335,351 shares of the company's stock worth $4,792,903,000 after purchasing an additional 3,064,673 shares in the last quarter. State Street Corp increased its holdings in shares of Exelon by 3.7% in the third quarter. State Street Corp now owns 60,169,219 shares of the company's stock worth $2,439,862,000 after buying an additional 2,156,259 shares during the period. Geode Capital Management LLC grew its position in Exelon by 1.6% during the 3rd quarter. Geode Capital Management LLC now owns 25,945,791 shares of the company's stock worth $1,048,823,000 after acquiring an additional 403,542 shares during the last quarter. Norges Bank purchased a new stake in shares of Exelon during the fourth quarter valued at approximately $479,597,000. Finally, Charles Schwab Investment Management Inc. increased its stake in shares of Exelon by 4.4% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 6,729,004 shares of the company's stock worth $253,280,000 after buying an additional 282,596 shares during the period. 80.92% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently commented on EXC shares. Guggenheim raised shares of Exelon from a "neutral" rating to a "buy" rating in a research report on Thursday, January 23rd. Morgan Stanley increased their price objective on Exelon from $46.00 to $48.00 and gave the company an "equal weight" rating in a research report on Thursday, March 20th. Barclays lifted their price objective on Exelon from $42.00 to $48.00 and gave the stock an "overweight" rating in a report on Tuesday, February 25th. UBS Group lifted their price target on shares of Exelon from $45.00 to $47.00 and gave the stock a "neutral" rating in a research note on Friday, March 21st. Finally, Scotiabank raised their price objective on Exelon from $42.00 to $44.00 and gave the stock a "sector perform" rating in a research note on Thursday, February 13th. Four investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat, Exelon has an average rating of "Moderate Buy" and an average target price of $45.13.
Check Out Our Latest Report on EXC
Exelon Price Performance
Shares of Exelon stock traded up $0.05 on Wednesday, hitting $45.97. The company's stock had a trading volume of 6,829,861 shares, compared to its average volume of 6,858,993. The company has a debt-to-equity ratio of 1.61, a quick ratio of 0.78 and a current ratio of 0.87. Exelon Co. has a 1 year low of $34.01 and a 1 year high of $46.46. The firm has a fifty day moving average price of $42.89 and a 200-day moving average price of $40.27. The company has a market capitalization of $46.41 billion, a price-to-earnings ratio of 18.76, a price-to-earnings-growth ratio of 2.86 and a beta of 0.51.
Exelon (NASDAQ:EXC - Get Free Report) last issued its earnings results on Wednesday, February 12th. The company reported $0.64 EPS for the quarter, beating analysts' consensus estimates of $0.59 by $0.05. Exelon had a net margin of 10.68% and a return on equity of 9.52%. During the same period in the previous year, the business earned $0.60 earnings per share. As a group, sell-side analysts anticipate that Exelon Co. will post 2.64 earnings per share for the current fiscal year.
Exelon Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were issued a $0.40 dividend. The ex-dividend date was Monday, February 24th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.48%. This is a boost from Exelon's previous quarterly dividend of $0.38. Exelon's payout ratio is 65.31%.
Insiders Place Their Bets
In other Exelon news, EVP Colette D. Honorable sold 1,463 shares of the business's stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $40.57, for a total value of $59,353.91. Following the completion of the sale, the executive vice president now owns 2,271 shares in the company, valued at approximately $92,134.47. The trade was a 39.18 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.10% of the company's stock.
Exelon Company Profile
(
Free Report)
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
Read More

Before you consider Exelon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.
While Exelon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.